Apitope starts new ATX-MS-1467 clinical trial

MSUK · Post by **MSUK** » Tue May 18, 2010 5:22 am

Apitope, the European biotech company developing therapeutic peptides to treat autoimmune and allergic diseases, today announced the start of its second Phase I clinical trial of ATX-MS-1467, in patients with Multiple Sclerosis (MS)...............

http://www.msrc.co.uk/index.cfm/fuseact ... ageid/2341

LR1234 · Post by **LR1234** » Tue May 18, 2010 5:26 am

By the Way Squiffs, I like it when you start new topics for each link. I can easily refind them and can read the ones I want. Also each one is a new topic, so I think each one should have a thread of discussion.

Bethr · Post by **Bethr** » Tue May 18, 2010 10:48 am

I agree. Best to start a new thread for each item as the subject matter can be very different.

Cheers.....